• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Cardiac software debuts

Article

Amersham Health launched analytical software designed to help practitioners better identify, measure, and manage costs associated with myocardial perfusion imaging studies on Jan. 8. MPOptions models economic factors affecting office-based and outpatient

Amersham Health launched analytical software designed to help practitioners better identify, measure, and manage costs associated with myocardial perfusion imaging studies on Jan. 8. MPOptions models economic factors affecting office-based and outpatient imaging centers and provides what-if scenarios to explore alternatives for delivering nuclear cardiology services efficiently and cost-effectively. The software calculates costs in several categories, including labor, capital equipment, facility, pharmaceutical, and supplies. MPOptions was developed with Amersham funding by physicians at Cardiovascular Consultants in St. Louis and Georgetown University in Washington, DC.

Recent Videos
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Related Content
© 2025 MJH Life Sciences

All rights reserved.